Complement receptor 1/CD35 is a receptor for mannan-binding lectin

被引:186
作者
Ghiran, I
Barbashov, SF
Klickstein, LB
Tas, S
Jensenius, JC
Nicholson-Weller, A
机构
[1] Beth Israel Deaconess Med Ctr, Harvard Thorndike Lab, Div Allergy & Inflammat, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Dept Med, Div Infect Dis, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Boston, MA 02215 USA
[4] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02215 USA
[5] Aarhus Univ, Dept Med Microbiol, DK-8000 Aarhus, Denmark
[6] Aarhus Univ, Dept Immunol, DK-8000 Aarhus, Denmark
关键词
C1q; opsonins; neutrophil; erythrocyte; innate immunity;
D O I
10.1084/jem.192.12.1797
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mannan-binding lectin (MBL), a member of the collectin family, is known to have opsonic function, although identification of its cellular receptor has been elusive. Complement C1q, which is homologous to MEL, binds to complement receptor 1 (CR1/CD35), and thus we investigated whether CR1 also functions as the MBL receptor. Radioiodinated MBL bound to recombinant soluble CR1 (sCR1) that had been immobilized on plastic with an apparent equilibrium dissociation constant of 5 nM. N-acetyl-D-glucosamine did not inhibit sCR1-MBL binding, indicating that the carbohydrate binding site of MBL is not involved in binding CR1. C1q inhibited MBL binding to immobilized sCR1, suggesting that MBL and C1q might bind to the same or adjacent sites on CR1. MBL binding to polymorphonuclear leukocytes (PMNs) was associated positively with changes in CR1 expression induced by phorbol myristate acetate. Finally, CR1 mediated the adhesion of human erythrocytes to immobilized MBL and functioned as a phagocytic receptor on PMNs for MBL-immunoglobulin G opsonized bacteria. Thus, MBL binds to both recombinant sCR1 and cellular CR1, which supports the role of CR1 as a cellular receptor for the collectin MBL.
引用
收藏
页码:1797 / 1807
页数:11
相关论文
共 54 条
[1]  
Bajtay Z, 2000, EUR J IMMUNOL, V30, P1706, DOI 10.1002/1521-4141(200006)30:6<1706::AID-IMMU1706>3.0.CO
[2]  
2-2
[3]   HUMAN-NEUTROPHILS INCREASE EXPRESSION OF C3BI AS WELL AS C3B RECEPTORS UPON ACTIVATION [J].
BERGER, M ;
OSHEA, J ;
CROSS, AS ;
FOLKS, TM ;
CHUSED, TM ;
BROWN, EJ ;
FRANK, MM .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (05) :1566-1571
[4]   C1Q ACTS SYNERGISTICALLY WITH PHORBOL DIBUTYRATE TO ACTIVATE CR1-MEDIATED PHAGOCYTOSIS BY HUMAN MONONUCLEAR PHAGOCYTES [J].
BOBAK, DA ;
FRANK, MM ;
TENNER, AJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (12) :2001-2007
[5]  
BOBAK DA, 1986, J IMMUNOL, V136, P4604
[6]  
BOBAK DA, 1987, J IMMUNOL, V138, P1150
[7]  
BOWNESS P, 1994, Q J MED, V87, P455
[8]  
CHANGELIAN PS, 1985, J IMMUNOL, V134, P1851
[9]   HUMAN LYMPHOCYTES-T EXPRESSING THE C3B/C4B COMPLEMENT RECEPTOR TYPE ONE (CR-1, CD35) BELONG TO FC-GAMMA RECEPTOR-POSITIVE CD4-POSITIVE T-CELLS [J].
COHEN, JHM ;
AUBRY, JP ;
REVILLARD, JP ;
BANCHEREAU, J ;
KAZATCHKINE, MD .
CELLULAR IMMUNOLOGY, 1989, 121 (02) :383-390
[10]   ICAM-1 (CD54) - A COUNTER-RECEPTOR FOR MAC-1 (CD11B CD18) [J].
DIAMOND, MS ;
STAUNTON, DE ;
DEFOUGEROLLES, AR ;
STACKER, SA ;
GARCIAAGUILAR, J ;
HIBBS, ML ;
SPRINGER, TA .
JOURNAL OF CELL BIOLOGY, 1990, 111 (06) :3129-3139